2026-01-22 - Analysis Report
**Company Overview**
UnitedHealth Group is a diversified healthcare company providing health insurance and other related services.

**Return Rate Comparison**
* Review Stock (UNH): -17.56%
* Comparison Stock (VOO): 91.55%
* Degree of Divergence: -114.80
* Relative Divergence: 6.30%

The divergence between review and comparison stock is significant, indicating a substantial underperformance of UNH compared to the S&P 500.

**Alpha, Beta Analysis**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2016-2018  | 22.0% | 18.6% | 18.0% | 0.9 | 225.7B |
| 2017-2019  | 27.0% | 18.6% | 10.0% | 0.9 | 266.3B |
| 2018-2020  | -41.0% | 32.5% | -62.0% | 1.1 | 317.7B |
| 2019-2021  | 16.0% | 32.5% | -27.0% | 1.1 | 454.9B |
| 2020-2022  | 0.0% | 31.5% | 2.0% | 0.9 | 480.3B |
| 2021-2023  | 23.0% | 13.4% | 23.0% | 0.5 | 476.9B |
| 2022-2024  | -24.0% | 23.1% | -44.0% | 0.4 | 458.2B |
| 2023-2025  | -55.0% | 58.5% | -118.0% | 0.3 | 299.0B |

The Alpha, Beta analysis suggests that UNH has experienced fluctuations in returns, with a significant underperformance in 2023-2025. The Beta values indicate a high level of volatility.

**Recent Stock Price Fluctuations**
* Close: $347.75
* Last-market: +2.75% ($347.75 - $338.43)
* 5-day SMA: $338.22
* 20-day SMA: $336.30
* 60-day SMA: $333.21

The recent stock price has shown a sharp rebound, with the last-market change indicating a +2.75% increase.

**RSI, PPO Index Indicators**
* Market Risk Indicator (MRI): 0.80
* RSI: 60.26
* PPO: 0.07
* Hybrid Signal: Buy (Cash 0%)
Risk Level: Medium (MRI 0.80)
Recent (20 days) relative divergence change: -1.60 (-): worsening
7-day Rank change: 46 (+): rank up
7-day Dynamic Expected Return change: -58.80 (-): worsening
Expected Return (%): -356.70%

The RSI and PPO indicators suggest a mixed signal, with a risk level of Medium. The hybrid signal indicates a buy recommendation, but the recent relative divergence change and dynamic expected return change indicate worsening trends.

**Recent News & Significant Events**

* [2026-01-04] Don't Buy UnitedHealth Group Stock Before Jan. 27 - The Motley Fool
* [2026-01-04] Don't Buy UnitedHealth Group Stock Before Jan. 27 - Yahoo Finance
* [2026-01-21] UnitedHealth rebating profits from ACA plans to customers (UNH:NYSE) - Seeking Alpha
* [2026-01-21] UnitedHealth Group (NYSE:UNH) Stock Price Up 2.3% - Here's Why - MarketBeat
* [2026-01-15] UNH Stock vs. CVS - Forbes
* [2026-01-20] UNH Stock Today: January 20 Insurer Hearings, Trump Plan Lift Policy Risk - Meyka

The recent news suggests that UNH has been experiencing fluctuations in stock price and regulatory changes.

**Analyst Opinions**

Analyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): 1.93 (~Buy)
- Opinions: 26
- Target Price (avg/high/low): 393.85 / 444.00 / 280.00

The analyst consensus suggests a buy recommendation with a target price of $393.85.

**Recent Earnings Analysis**

| Date | EPS | Revenue |
|---|---:|---:|
| 2025-10-28 | 2.59 | $113.16 B$ |
| 2025-08-11 | 3.76 | $111.62 B$ |
| 2025-05-07 | 6.9 | $109.58 B$ |
| 2024-11-04 | 6.56 | $100.82 B$ |
| 2025-10-28 | 6.56 | $100.82 B$ |

The recent earnings analysis suggests that UNH has experienced fluctuations in EPS and revenue, with a significant underperformance in 2025-2023.

**Revenue and Profitability**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $113.16B | 18.24% |
| 2025-06-30 | $111.62B | 17.93% |
| 2025-03-31 | $109.58B | 21.70% |
| 2024-12-31 | $100.81B | 21.14% |
| 2024-09-30 | $100.82B | 22.84% |

The revenue and profitability analysis suggests that UNH has experienced fluctuations in revenue and profit margin, with a significant underperformance in 2025-2023.

**Capital and Profitability**

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $95.79B | 2.45% |
| 2025-06-30 | $94.72B | 3.60% |
| 2025-03-31 | $95.04B | 6.62% |
| 2024-12-31 | $92.66B | 5.98% |
| 2024-09-30 | $94.53B | 6.41% |

The capital and profitability analysis suggests that UNH has experienced fluctuations in equity and ROE, with a significant underperformance in 2025-2023.

**Comprehensive Analysis (Summary of previous items)**

The comprehensive analysis suggests that UNH has experienced significant fluctuations in stock price, earnings, and profitability, with a significant underperformance compared to the S&P 500. The analyst consensus suggests a buy recommendation, but the recent relative divergence change and dynamic expected return change indicate worsening trends. The hybrid signal indicates a buy recommendation, but the risk level is Medium. The market risk indicator suggests a medium risk level, and the recent news suggests that UNH has been experiencing fluctuations in stock price and regulatory changes.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.